Otonomy, Inc.
San Diego, CA, US· latest recorded location
OTONOMY, INC. is named on 42 US grants and 75 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 42
- Published applications
- 75
- Inventors
- 29
- Granted in 2026 so far
- 0
- Most recent grant
- 21 Sep 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 4 |
| 2010 | 0 | 10 |
| 2011 | 1 | 5 |
| 2012 | 1 | 2 |
| 2013 | 5 | 4 |
| 2014 | 9 | 5 |
| 2015 | 4 | 4 |
| 2016 | 5 | 11 |
| 2017 | 4 | 5 |
| 2018 | 3 | 7 |
| 2019 | 2 | 7 |
| 2020 | 3 | 3 |
| 2021 | 5 | 4 |
| 2022 | 0 | 2 |
| 2023 | 0 | 2 |
By publication year.
Technology areas
Share of 117 documents
- A61KMedicines and medical preparations117
- A61PTherapeutic uses of medicines103
- C07KPeptides18
- C12NMicroorganisms or enzymes7
- Y02ATechnologies for adaptation to climate change7
- A61LMethods or apparatus for sterilising materials or objects in general4
- A61BMedical diagnosis and surgery1
- A61FFilters implantable into blood vessels1
- A61MDevices for delivering substances into the body1
Recent patents
- Auris formulations for treating OTIC diseases and conditions21 Sep 2021US 11,123,285 B2
- Auris formulations for treating otic diseases and conditions21 Sep 2021US 11,123,286 B2
- Otic gel formulations for treating otitis externa22 Jun 2021US 11,040,004 B2
- Treatment using truncated Trk B and Trk C antagonists15 Jun 2021US 11,034,961 B2
- Controlled-release CNS modulating compositions and methods for the treatment of otic disorders16 Feb 2021US 10,918,594 B2
- Growth factor otic formulations22 Jun 2023US 2023/0190642 A1
- Growth factor formulation for condition associated with otic event20 Apr 2023US 2023/0122991 A1
- Auris formulations for treating otic diseases and conditions10 Feb 2022US 2022/0040095 A1
- Auris formulations for treating otic diseases and conditions10 Feb 2022US 2022/0040096 A1
- Otic gel formulations for treating otitis externa23 Dec 2021US 2021/0393511 A1
Most cited
By later US patents
- Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders55US 8,030,297 B22011
- Controlled release ion channel modulator compositions and methods for the treatment of otic disorders40US 8,399,018 B22013
- Controlled release antimicrobial compositions and methods for the treatment of otic disorders33US 8,318,817 B22012
- Controlled release compositions for modulating free-radical induced damage and methods of use thereof33US 8,784,870 B22014
- Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders31US 8,846,770 B22014